anmelden
AstraZeneca Aktie
146,10
EUR
+1,15
EUR
+0,79
%
125,52
GBP
+1,52
GBP
+1,23
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 223,64 Mrd. EUR
KGV 27,55Div. Rendite 1,71%WKN 886455
ISIN GB0009895292
Symbol AZN
AI Analyse
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| UBS AG | 152,00 GBP | - | 16.09.2026 | |
| Jefferies & Company Inc. | 175,00 GBP | - | 16.09.2026 | |
| JP Morgan Chase & Co. | 160,00 GBP | - | 16.09.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 150,00 GBP | - | 15.09.2026 | |
| Deutsche Bank AG | 117,00 GBP | - | 15.09.2026 | |
| RBC Capital Markets | 145,00 GBP | - | 09.09.2026 | |
| Barclays Capital | 160,00 GBP | - | 08.09.2026 | |
| Goldman Sachs Group Inc. | 163,00 GBP | - | 20.08.2026 | |
| Bernstein Research | 202,00 GBP | - | 29.07.2026 | |
| DZ BANK | - | - | 28.07.2026 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Alexion Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| APONTIS PHARMA | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 9 | 1 | 0 | 158,22 GBP | - |
| Bayer | 7 | 2 | 0 | 56,56 EUR | +13,53% |
| BioNTech (ADRs) | 5 | 1 | 0 | 129,33 USD | +31,27% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| Celgene Corp. | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| EVOTEC SE | 1 | 2 | 0 | 5,70 EUR | +102,85% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 3 | 5 | 0 | 147,57 EUR | +8,47% |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -77,37% |
| Novartis AG | 1 | 8 | 1 | 120,35 CHF | +0,46% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 5 | 1 | 27,14 USD | -5,34% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Roche Holding AG Inhaber-Partizipationsschein | 2 | 2 | 0 | - | - |
| Sanofi S.A. | 5 | 5 | 0 | 93,53 EUR | +30,88% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |
